These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 18798127)

  • 1. [Loss of differentiation of a prostate adenocarcinoma after hormone therapy: the example of a metastasis in the spongy body of the penis].
    Uphoff J; Woziwodzki J; Schattka SO; Kollias A
    Aktuelle Urol; 2008 Sep; 39(5):373-7. PubMed ID: 18798127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case records of the Massachusetts General Hospital. Case 16-2011. A 67-year-old man with recurrent prostate cancer.
    Smith MR; Zietman AL; Finkelstein JS; Wu CL
    N Engl J Med; 2011 May; 364(21):2044-51. PubMed ID: 21612474
    [No Abstract]   [Full Text] [Related]  

  • 3. [Neuroendocrine differentiation in adenocarcinoma of prostate during combined androgen blockade therapy: a case report].
    Kitamoto K; Hayashi T; Tamada S; Ezaki K; Kawashima H; Sugimura K; Nakatani T
    Hinyokika Kiyo; 2005 Jan; 51(1):33-5. PubMed ID: 15732339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroendocrine differentiation in adenocarcinoma of the prostate during hormonal treatment: a case report].
    Matsumoto Y; Mibu H; Kagebayashi Y
    Hinyokika Kiyo; 2004 Nov; 50(11):813-5. PubMed ID: 15628545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prostate cancer with penile metastasis: a case report].
    Sawada A; Segawa T; Nakanishi S; Kinoshita H; Yamamoto S; Kamoto T; Ogawa O
    Hinyokika Kiyo; 2005 Nov; 51(11):771-3. PubMed ID: 16363713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormone refractory prostate carcinoma metastasizes to the penis: a case report].
    Kawahara T; Manabe Y; Asazuma A; Aoyama T; Hashimura T
    Hinyokika Kiyo; 2009 Oct; 55(10):627-9. PubMed ID: 19938335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difficulties in interpreting specimens after neoadjuvant hormonal therapy and radiation with illustration of neuroendocrine differentiation.
    Civantos F
    Mol Urol; 2000; 4(3):117-21; discussion 123. PubMed ID: 11062365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
    Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
    Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone-resistant epithelial cancer of the prostate].
    Medvedev VL
    Urologiia; 2001; (4):29-33. PubMed ID: 11569231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer metastatic only to the penis.
    Celebi MM; Venable DD; Nopajaroonsri C; Eastham JA
    South Med J; 1997 Sep; 90(9):959-61. PubMed ID: 9305314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endometrioid adenocarcinoma of the prostate: report of 3 cases].
    Uemura M; Nakagawa M; Kanno N; Nishimura K; Miyoshi S; Kawano K
    Hinyokika Kiyo; 2004 Nov; 50(11):825-8. PubMed ID: 15628548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine cells in the prostatic carcinomas after neoadjuvant hormonal therapy.
    Chen X; Okada H; Gotoh A; Arakawa S; Kamidono S
    Kobe J Med Sci; 1997 Apr; 43(2):71-81. PubMed ID: 9385786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of somatostatin analogues and dexamethasone (anti-survival-factor concept) with luteinizing hormone-releasing hormone in androgen ablation-refractory prostate cancer with bone metastasis.
    Koutsilieris M; Dimopoulos T; Milathianakis C; Bogdanos J; Karamanolakis D; Pissimissis N; Halapas A; Lembessis P; Papaioannou A; Sourla A
    BJU Int; 2007 Jul; 100 Suppl 2():60-2. PubMed ID: 17594363
    [No Abstract]   [Full Text] [Related]  

  • 14. Preservation of bone health in prostate cancer.
    Lattouf JB; Saad F
    Curr Opin Support Palliat Care; 2007 Oct; 1(3):192-7. PubMed ID: 18685362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate].
    Berenguer Sánchez A
    Arch Esp Urol; 2002 Sep; 55(7):771-5. PubMed ID: 12380304
    [No Abstract]   [Full Text] [Related]  

  • 16. Transitional cell carcinoma of the prostate metastatic to penis as cause of priapism.
    Rodrigues Netto N; de Almeida Claro JF; Balthazar Saldanha L
    Arch Esp Urol; 1990 Apr; 43(3):321-2. PubMed ID: 2369166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer: the role of hormonal therapy.
    Salesi N; Carlini P; Ruggeri EM; Ferretti G; Bria E; Cognetti F
    J Exp Clin Cancer Res; 2005 Jun; 24(2):175-80. PubMed ID: 16110748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coincidence of adenocarcinoma and MALT lymphoma of the prostate--first report].
    Uthoff D; Schmidt S; Matthies C; Tiemann M; Wagner W
    Aktuelle Urol; 2009 Mar; 40(2):113-5. PubMed ID: 19177323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced prostate cancer. Hormonal treatment.
    de la Haba-Rodríguez J
    Tunis Med; 2005 Dec; 83 Suppl 12():71-3. PubMed ID: 16430072
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of gonadotropin-releasing hormone agonists with and without sterile abscess formation at depot sites: insight into mechanisms?
    Daskivich TJ; Oh WK
    Urology; 2006 May; 67(5):1084.e15-7. PubMed ID: 16698377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.